$ARDX
ARDELYX, INC.

2015 Q2 Form 10-Q Financial Statement

#000119312515288082 Filed on August 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $18.14M $9.137M
YoY Change 98.57% 25.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.890M $1.200M
YoY Change 140.83% 31.87%
% of Gross Profit
Research & Development $6.198M $5.183M
YoY Change 19.58% -28.31%
% of Gross Profit
Depreciation & Amortization $160.0K $60.00K
YoY Change 166.67% -66.67%
% of Gross Profit
Operating Expenses $9.087M $6.386M
YoY Change 42.3% -21.57%
Operating Profit $9.056M $2.751M
YoY Change 229.19%
Interest Expense $0.00 $1.010M
YoY Change -100.0%
% of Operating Profit 0.0% 36.71%
Other Income/Expense, Net -$49.00K -$8.000K
YoY Change 512.5%
Pretax Income $9.007M $3.753M
YoY Change 139.99% -536.4%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $9.007M $3.753M
YoY Change 139.99% -521.21%
Net Earnings / Revenue 49.64% 41.07%
Basic Earnings Per Share $0.43 $0.20
Diluted Earnings Per Share $0.42 $0.18
COMMON SHARES
Basic Shares Outstanding 20.88M shares 2.611M shares
Diluted Shares Outstanding 21.64M shares 3.904M shares

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $141.5M $117.8M
YoY Change 20.12%
Cash & Equivalents $141.5M $117.8M
Short-Term Investments
Other Short-Term Assets $2.400M $1.300M
YoY Change 84.62%
Inventory
Prepaid Expenses
Receivables $27.00K $3.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $143.9M $122.1M
YoY Change 17.87%
LONG-TERM ASSETS
Property, Plant & Equipment $4.061M $1.100M
YoY Change 269.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $104.0K $200.0K
YoY Change -48.0%
Total Long-Term Assets $4.265M $1.400M
YoY Change 204.64%
TOTAL ASSETS
Total Short-Term Assets $143.9M $122.1M
Total Long-Term Assets $4.265M $1.400M
Total Assets $148.2M $123.5M
YoY Change 19.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.684M $2.300M
YoY Change 16.7%
Accrued Expenses $2.900M $1.800M
YoY Change 61.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.546M $27.30M
YoY Change -79.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $382.0K $33.30M
YoY Change -98.85%
Total Long-Term Liabilities $382.0K $33.30M
YoY Change -98.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.546M $27.30M
Total Long-Term Liabilities $382.0K $33.30M
Total Liabilities $5.928M $60.60M
YoY Change -90.22%
SHAREHOLDERS EQUITY
Retained Earnings -$66.36M
YoY Change
Common Stock $208.6M $2.000K
YoY Change 10431000.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $142.3M $62.90M
YoY Change
Total Liabilities & Shareholders Equity $148.2M $123.5M
YoY Change 19.99%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income $9.007M $3.753M
YoY Change 139.99% -521.21%
Depreciation, Depletion And Amortization $160.0K $60.00K
YoY Change 166.67% -66.67%
Cash From Operating Activities -$30.22M $23.99M
YoY Change -225.97% -602.94%
INVESTING ACTIVITIES
Capital Expenditures -$1.260M -$650.0K
YoY Change 93.85% 242.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.260M -$650.0K
YoY Change 93.85% 242.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $74.30M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 74.70M 61.24M
YoY Change 21.98%
NET CHANGE
Cash From Operating Activities -30.22M 23.99M
Cash From Investing Activities -1.260M -650.0K
Cash From Financing Activities 74.70M 61.24M
Net Change In Cash 43.22M 84.58M
YoY Change -48.9% -1805.24%
FREE CASH FLOW
Cash From Operating Activities -$30.22M $23.99M
Capital Expenditures -$1.260M -$650.0K
Free Cash Flow -$28.96M $24.64M
YoY Change -217.53% -637.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25924232 shares
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117814000
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.125
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25911537 shares
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2172899 shares
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
142260000
CY2015Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
382000
CY2015Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2684000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66362000
CY2015Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25911537 shares
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.70
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
208619000
CY2015Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1405000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1457000
CY2015Q2 us-gaap Liabilities
Liabilities
5928000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
148188000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5546000
CY2015Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2015Q2 us-gaap Assets
Assets
148188000
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27000
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4061000
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
100000
CY2015Q2 us-gaap Assets Current
AssetsCurrent
143923000
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2362000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
141534000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34435000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18589245 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18589245 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132547000
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
780000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1648000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
60682000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
122000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15979000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3129000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71867000
CY2014Q4 us-gaap Liabilities
Liabilities
52732000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113414000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
31074000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21536000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
104000
CY2014Q4 us-gaap Assets
Assets
113414000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2584000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2131000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
100000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
111079000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1209000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107286000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
22874000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1100000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1937509 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1937509 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
7944000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
736000
us-gaap Net Income Loss
NetIncomeLoss
682000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0
us-gaap Revenues
Revenues
17687000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2000
us-gaap Operating Income Loss
OperatingIncomeLoss
2287000
us-gaap Licenses Revenue
LicensesRevenue
9743000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3411000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
682000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16093000
us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Share Based Compensation
ShareBasedCompensation
163000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1593000
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
682000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
903000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
83379000
us-gaap Operating Expenses
OperatingExpenses
15400000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-736000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
499000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
61241000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12820000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
61241000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-125000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2580000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Depreciation
Depreciation
128000
ardx Weighted Average Private Placement Warrants Outstanding
WeightedAveragePrivatePlacementWarrantsOutstanding
0 shares
ardx Common Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
CommonStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-38433000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001437402
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Ardelyx, Inc.
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20506916 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
724890 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19749778 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although management believes these estimates are based upon reasonable assumptions within the bounds of its knowledge of the Company&#x2019;s business and operations, actual results could differ materially from those estimates.</p> </div>
dei Trading Symbol
TradingSymbol
ARDX
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2415000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2320000
us-gaap Net Income Loss
NetIncomeLoss
5505000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5505000
us-gaap Revenues
Revenues
24026000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
959000
us-gaap Operating Income Loss
OperatingIncomeLoss
5566000
us-gaap Licenses Revenue
LicensesRevenue
21611000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-61000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2557000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-11000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
515000
CY2014Q2 us-gaap Revenues
Revenues
9137000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6064000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5505000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
310000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5505000
us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Share Based Compensation
ShareBasedCompensation
1165000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-47053000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
886000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34248000
us-gaap Operating Expenses
OperatingExpenses
18460000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2320000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
134000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
75001000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12396000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74654000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-192000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
317000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1165000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-631000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
30000
us-gaap Depreciation
Depreciation
278000
ardx Class Of Warrant Or Right Expiration Date Description
ClassOfWarrantOrRightExpirationDateDescription
The warrants are exercisable for an exercise price of $13.91 per share at any time prior to the earlier of (i) 5 years from the date of issuance or (ii) certain changes in control of the Company.
ardx Weighted Average Private Placement Warrants Outstanding
WeightedAveragePrivatePlacementWarrantsOutstanding
32248 shares
ardx Common Stock Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
CommonStockIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
287000
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7242992 shares
CY2015Q2 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
13.91
CY2015Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
74400000
CY2015Q2 ardx Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
77800000
CY2015Q2 ardx Warrant Expiration Term
WarrantExpirationTerm
P5Y
CY2015Q2 ardx Class Of Warrant Or Right Threshold Ownership Percentage
ClassOfWarrantOrRightThresholdOwnershipPercentage
0.0999 pure
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
527205 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3904136 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
765672 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2611259 shares
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2014Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2630000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
3753000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2751000
CY2014Q2 us-gaap Licenses Revenue
LicensesRevenue
6507000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3753000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
703000
CY2014Q2 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
188000
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1010000
CY2014Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1099000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
6386000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5183000
CY2014Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2139000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
99000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1203000
CY2014Q2 ardx Weighted Average Private Placement Warrants Outstanding
WeightedAveragePrivatePlacementWarrantsOutstanding
0 shares
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2015Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21636487 shares
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
692110 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20880235 shares
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2015Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
416000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
9007000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9007000
CY2015Q2 us-gaap Revenues
Revenues
18143000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9056000
CY2015Q2 us-gaap Licenses Revenue
LicensesRevenue
17727000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9007000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
9007000
CY2015Q2 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
9087000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6198000
CY2015Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
641000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2889000
CY2015Q2 ardx Class Of Warrant Or Right Number Of Warrants Exercised
ClassOfWarrantOrRightNumberOfWarrantsExercised
0 shares
CY2015Q2 ardx Weighted Average Private Placement Warrants Outstanding
WeightedAveragePrivatePlacementWarrantsOutstanding
64142 shares

Files In Submission

Name View Source Status
0001193125-15-288082-index-headers.html Edgar Link pending
0001193125-15-288082-index.html Edgar Link pending
0001193125-15-288082.txt Edgar Link pending
0001193125-15-288082-xbrl.zip Edgar Link pending
ardx-20150630.xml Edgar Link completed
ardx-20150630.xsd Edgar Link pending
ardx-20150630_cal.xml Edgar Link unprocessable
ardx-20150630_def.xml Edgar Link unprocessable
ardx-20150630_lab.xml Edgar Link unprocessable
ardx-20150630_pre.xml Edgar Link unprocessable
d948397d10q.htm Edgar Link pending
d948397dex101.htm Edgar Link pending
d948397dex102.htm Edgar Link pending
d948397dex311.htm Edgar Link pending
d948397dex312.htm Edgar Link pending
d948397dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending